Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

You may be eligible if

• Have been exposed to AVONEX within approximately 1 week of conception or during the first trimester of pregnancy.
• Provide sufficient information to determine that the pregnancy is prospectively registered (i.e., the outcome of pregnancy must be unknown prospectively).
• Provide verbal consent to participate in the Registry.
• Verbally provide contact information for herself, her HCP, and the infant's HCP (if applicable).